These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8798923)

  • 1. Study of the biotransformation of a potential benzo[c]fluorene antineoplastic using high-performance liquid chromatography with high-speed-scanning ultraviolet detection.
    Nobilis M; Anzenbacher P; Pastera J; Svoboda Z; Hrubý K; Kvĕtina J; Ubik K; Trejtnar F
    J Chromatogr B Biomed Appl; 1996 May; 681(1):143-51. PubMed ID: 8798923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the biotransformation of benfluron using the isolated perfused rat liver.
    Svoboda Z; Nobilis M; Kvĕtina J; Lemr K
    Acta Medica (Hradec Kralove); 1999; 42(2):73-8. PubMed ID: 10596420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of benfluron and its metabolites in the faeces and urine of rats.
    Nobilis M; Kvasnicková E; Sroler A; Hais IM
    Drug Metabol Drug Interact; 1991; 9(3-4):225-40. PubMed ID: 1824077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of substituents on microsomal reduction of benzo(c)fluorene N-oxides.
    Skálová L; Nobilis M; Szotáková B; Wsól V; Kubícek V; Baliharová V; Kvasnicková E
    Chem Biol Interact; 2000 Jun; 126(3):185-200. PubMed ID: 10862817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition study of a new potential antineoplastic agent dimefluron in rats using high-performance liquid chromatography with ultraviolet and mass spectrometric detection.
    Císar P; Nobilis M; Vybíralová Z; Holcapek M; Kolárová L; Pour M; Kunes J; Klimes J
    J Pharm Biomed Anal; 2005 Apr; 37(5):1059-71. PubMed ID: 15862686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rat hepatocytes immobilized in agarose gel threads for biosynthesis of metabolites of potential cytostatics.
    Trejtnar F; Skálová L; Szotáková B; Wsól V
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):432-5. PubMed ID: 10445411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of chiral liquid chromatography for the evaluation of stereospecificity in the carbonyl reduction of potential benzo[c]fluorene antineoplastics benfluron and dimefluron in various species.
    Kucera R; Nobilis M; Skálová L; Szotáková B; Císar P; Jira T; Klimes J; Wsól V
    J Pharm Biomed Anal; 2005 Apr; 37(5):1049-57. PubMed ID: 15862685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatographic characterization of in vitro metabolites of 5-[2-(N,N-dimethylamino)ethoxy]-7-oxo-7H-benzo[c]fluorene.
    Kvasnicková E; Nobilis M; Hais IM
    J Chromatogr; 1984 Jul; 295(1):201-9. PubMed ID: 6470084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of phase I and phase II metabolites of benfluron and dimefluron in rat urine using high-performance liquid chromatography/tandem mass spectrometry.
    Jirásko R; Holčapek M; Nobilis M
    Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2153-62. PubMed ID: 21710595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of the new ribonucleotide reductase inhibitor amidox in the isolated perfused rat liver.
    Salamon A; Vielnascher E; Hagenauer B; Szekeres T; Szekeres-Fritzer M; Thalhammer T; Jäger W
    Anticancer Res; 2000; 20(5B):3521-6. PubMed ID: 11131656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of topotecan in the isolated perfused rat liver: identification of three novel metabolites.
    Platzer P; Schaden S; Thalhammer T; Hamilton G; Rosenberg B; Silgoner I; Jäger W
    Anticancer Res; 1998; 18(4A):2695-700. PubMed ID: 9703931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the dopamine D2 agonist N-0923 and its major metabolites in perfused rat livers by HPLC-UV-atmospheric pressure ionization mass spectrometry.
    Swart PJ; Oelen WE; Bruins AP; Tepper PG; de Zeeuw RA
    J Anal Toxicol; 1994; 18(2):71-7. PubMed ID: 7911536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of metabolites of benzo[j]fluoranthene formed in vitro in rat liver homogenate.
    Rice JE; Geddie NG; Lavoie EJ
    Chem Biol Interact; 1987; 63(3):227-37. PubMed ID: 3677219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of [14C]naphthalene in the B6C3F1 murine isolated perfused liver.
    Tsuruda LS; Lamé MW; Jones AD
    Drug Metab Dispos; 1995 Jan; 23(1):129-36. PubMed ID: 7720516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-species comparison of microsomal reductive transformation of biologically active benfluron N-oxide.
    Skálová L; Nobilis M; Szotáková B; Wsól V; Kvasnicková E
    Drug Metabol Drug Interact; 1998; 14(4):235-50. PubMed ID: 10694931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of conjugates of 2-fluoro-beta-alanine and bile acids during the metabolism of 5-fluorouracil and 5-fluoro-2-deoxyuridine in the isolated perfused rat liver.
    Sweeny DJ; Barnes S; Diasio RB
    Cancer Res; 1988 Apr; 48(8):2010-4. PubMed ID: 2964897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver.
    Jäger W; Zembsch B; Wolschann P; Pittenauer E; Senderowicz AM; Sausville EA; Sedlacek HH; Graf J; Thalhammer T
    Life Sci; 1998; 62(20):1861-73. PubMed ID: 9600328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of metabolites of benzo[b]fluoranthene.
    Amin S; LaVoie EJ; Hecht SS
    Carcinogenesis; 1982; 3(2):171-4. PubMed ID: 7067045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver organotropism and biotransformation of a novel platinum-ursodeoxycholate derivative, Bamet-UD2, with enhanced antitumour activity.
    Larena MG; Martinez-Diez MC; Monte MJ; Dominguez MF; Pascual MJ; Marin JJ
    J Drug Target; 2001 Jun; 9(3):185-200. PubMed ID: 11697204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonyl reduction of the potential cytostatic drugs benfluron and 3,9-dimethoxybenfluron in human in vitro.
    Skálová L; Nobilis M; Szotáková B; Kondrová E; Savlík M; Wsól V; Pichard-Garcia L; Maser E
    Biochem Pharmacol; 2002 Jul; 64(2):297-305. PubMed ID: 12123751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.